Personal tools
Sections
You are here: Home Publications 2002
Document Actions

2002

Up one level Last modified February 02, 2007 09:21 AM - EST
This folder holds the following references to publications, sorted by year and author:

Whellan, DJ, Cohen, EJ, Matchar, DB, and Califf, RM (2002).
Disease management in healthcare organizations: results of in-depth interviews with disease management decision makers
.

Wikstrand, CJ, Cole, VR, Crotty, LE, Sampson, JH, and Bigner, DD (2002).
Generation of anti-idiotypic reagents in the EGFRvIII tumor-associated antigen system
.

Wilkes, NJ, Woolf, RL, Powanda, MC, Gan, TJ, Machin, SJ, Webb, A, Mutch, M, Bennett-Guerrero, E, and Mythen, M (2002).
Hydroxyethyl starch in balanced electrolyte solution (Hextend)--pharmacokinetic and pharmacodynamic profiles in healthy volunteers
.

Wong, CK, French, JK, Krucoff, MW, Gao, W, Aylward, PE, and White, HD (2002).
Slowed ST segment recovery despite early infarct artery patency in patients with Q waves at presentation with a first acute myocardial infarction. Implications of initial Q waves on myocyte reperfusion
.

Wong, CK, White, HD, Wilcox, RG, Criger, DA, Califf, RM, Topol, EJ, and Ohman, EM (2002).
Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries
.

Yata, Y, Gotwals, P, Koteliansky, V, and Rockey, DC (2002).
Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-beta soluble receptor: implications for antifibrotic therapy
.

Young, SL, Evans, K, and Eu, JP (2002).
Nitric oxide modulates branching morphogenesis in fetal rat lung explants
.

Yu, Q, Que, LG, and Rockey, DC (2002).
Adenovirus-mediated gene transfer to nonparenchymal cells in normal and injured liver
.

Zijlstra, F, Patel, A, Jones, M, Grines, CL, Ellis, S, Garcia, E, Grinfeld, L, Gibbons, RJ, Ribeiro, EE, Ribichini, F, Granger, C, Akhras, F, Weaver, WD, and Simes, RJ (2002).
Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction
.

 

This site conforms to the following standards: